Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04523779 · ClinicalTrials.gov registry record · NA
A Pragmatic Trial of Brief CBT for Anxiety in VA Primary Care
A NA study of Anxiety, sponsored by VA Office of Research and Development.
- Active
- Registry status
- NA
- Development phase
- 225
- Enrollment target
- 3
- Study locations
NCT04523779: Active NA study of Anxiety, sponsored by VA Office of Research and Development.
NCT04523779 is a NA study of Anxiety that is active but no longer recruiting, run by VA Office of Research and Development. The registered enrollment target is 225 participants, below the 439-participant average among 364 other Anxiety trials with a reported enrollment target (49% lower). The trial reports 3 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04523779, a NA study of Anxiety, is active but no longer recruiting, sponsored by VA Office of Research and Development.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 225 participants
- Enrollment target
- 3
- Study locations
Study Summary
This 4-year study will examine the value of a type of a brief cognitive behavioral therapy treatment for Veterans with anxiety and worry. This treatment will be delivered either in-person, or by video telehealth to the Veteran's home. The treatment will be delivered by providers at three Veterans Administration Medical Centers (Houston, New Orleans, and San Antonio). The study will compare the helpfulness of this treatment to the usual care Veterans receive for anxiety and worry. A supplement to this study will also evaluate daily discrimination experiences of Veterans based on the participant's race, ethnicity, religion, physical appearance, or other characteristics.
Primary Outcome
The GAD-7 is a seven-item self-report instrument for screening, diagnosis, and severity assessment of anxiety disorders. It is psychometrically strong and valid for use in the primary care setting. A GAD-7 score of 10 or higher will be required for study inclusion. The GAD-7 total score for the seven items ranges from 0 to 21: 0-4 Minimal anxiety; 5-9 Mild anxiety; 10-14 Moderate anxiety; 15-21 Severe anxiety.
Conditions Studied
Interventions
- BEHAVIORAL Brief Cognitive Behavioral Therapy
Study Locations (3)
Texas
- Michael E. DeBakey VA Medical Center, Houston, TX - Houston
- South Texas Health Care System, San Antonio, TX - San Antonio
Louisiana
- Southeast Louisiana Veterans Health Care System, New Orleans, LA - New Orleans
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 225 participants |
| Start Date | 2022-01-03 |
| Est. Completion | 2026-05-31 |
| Phase | NA |
What the registry record for NCT04523779 still lists
NCT04523779 is an interventional study that assigns participants to a tested intervention. The registered 225 participants enrollment target is mid-sized for trials with a published cap, below the 439-participant average among 364 other Anxiety trials with a reported enrollment target (49% lower).
The record links to 1 condition, with Anxiety appearing as the primary indexed condition, and to 1 intervention - of which Brief Cognitive Behavioral Therapy is the first listed.
NCT04523779 reports a single indexed study location in Texas, Louisiana.
Frequently Asked Questions
What is clinical trial NCT04523779 about?
NCT04523779 is a clinical study titled "A Pragmatic Trial of Brief CBT for Anxiety in VA Primary Care". This 4-year study will examine the value of a type of a brief cognitive behavioral therapy treatment for Veterans with anxiety and worry. This treatment will be delivered either in-person, or by video telehealth to the Veteran's home. The treatment will be delivered by providers at three Veterans Ad...
What is the current status of trial NCT04523779?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 225 participants. The study started on 2022-01-03. Estimated completion is 2026-05-31.
What conditions does trial NCT04523779 study?
This clinical trial studies the following conditions: Anxiety.
What interventions are being tested in trial NCT04523779?
The interventions under investigation include: Brief Cognitive Behavioral Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT04523779?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04523779 being conducted?
This trial has 3 study locations across Louisiana, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anxiety
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04523779's enrollment target sits among peer trials
225 77th of 364 higher than 287 of 364 other Anxiety trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Anxiety trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Focused Ultrasound for the Complex Patient
RECRUITING · NA
-
Digital Intervention for Physical Activity
RECRUITING · NA
-
Exploring Virtual Reality Adventure Training Exergaming
RECRUITING · NA
-
Brief Interventions for Coping with Distress
RECRUITING · NA
-
Personalized Feedback Intervention for Latinx Drinkers With Anxiety
RECRUITING · NA
-
Pilot Effectiveness Trial of an ACT Self-help Workbook Tailored Specifically for Prisons
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03955445 · 225 participants · Phase 3
Long-term Efficacy, Safety and Tolerability of Iptacopan in C3G or IC-MPGN
- NCT04054310 · 225 participants · NA
Non-Invasive Quantification of Liver Health in NASH (N-QUAN)
- NCT04480554 · 225 participants · Phase 2
Anti-retroviral Therapy, Medications for Opioid Use Disorder, Opioids and HIV Infection - Study 1
- NCT04888104 · 225 participants
Prospective, Multicenter, Case-Control Analysis of the VersaTie Posterior Fixation System to Prevent Proximal Junctional Failure in Long Posterior Spinal Fusion Constructs for Adult Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI